Suven Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
271.84
248.85
269.98
234.16
250.90
Other Income Qtr Cr14.1218.1617.0514.3419.84
Operating Revenues Qtr257.72230.69252.93219.82231.05

*All values are in Cr.

Operating Expenses Qtr
153.71
150.76
179.59
154.68
133.09
Operating Profit Qtr
104.01
79.93
73.34
65.14
97.96
EBIDT Qtr Cr
118.13
98.09
90.40
79.49
117.80
Depreciation Qtr
16.96
13.40
17.25
12.75
11.89
Net Profit Qtr
82.21
60.77
53.37
46.75
79.56
Basic EPS Qtr
3.23
2.39
2.10
1.84
3.13
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -